Cancer-testing company raises $494 million in initial public offering.

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite ...

CareTrust stock has been forming a cup-with-handle since November. It's also near a 29.75 buy point, according to MarketSurge.

Cancer patients say they’ve grown sicker since Argentina’s radical libertarian President Javier Milei took his chainsaw to ...

Jassy called generative AI a “once-in-a-lifetime” technology that will change the way the company operates, and said Amazon ...

Deal would add a potential treatment for cardiovascular disease to Eli Lilly's portfolio. The food giant says it will remove the dyes from products including Jell-O, Kool-Aid and Crystal Light before ...

The Medical Services sector is experiencing significant transformation fueled by advancements in technology, increased ...

Microsoft (NASDAQ: MSFT) continues to provide investors with earnings beats and strong growth in its cloud, AI and gaming ...

The AMA at its annual meeting adopted multiple policies aimed at strengthening medical education and the future physician ...

In a recent survey of abortion-providing clinicians, 42% who practiced in a state that banned abortion after the Dobbs ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher and trending. The company on Tuesday announced a reduction in personnel and infrastructure aimed at extending its cash runway.

Citation: Sea change in cancer care requires urgent action to strengthen oncology workforce and care delivery, say researchers (2025, June 2) retrieved 14 June 2025 from https://medicalxpress.com ...